| Literature DB >> 27679668 |
Olivia A Thompson1, Gary M Hawkins1, Steven W Gorsich2, Joy Doran-Peterson1.
Abstract
BACKGROUND: Lignocellulosic biomass continues to be investigated as a viable source for bioethanol production. However, the pretreatment process generates inhibitory compounds that impair the growth and fermentation performance of microorganisms such as Saccharomyces cerevisiae. Pinewood specifically has been shown to be challenging in obtaining industrially relevant ethanol titers. An industrial S. cerevisiae strain was subjected to directed evolution and adaptation in pretreated pine biomass and resultant strains, GHP1 and GHP4, exhibited improved growth and fermentative ability on pretreated pine in the presence of related inhibitory compounds. A comparative transcriptomic approach was applied to identify and characterize differences in phenotypic stability of evolved strains.Entities:
Keywords: Bioethanol; Fermentation; Inhibitor tolerance; Lignocellulose; Saccharomyces; Transcriptomics
Year: 2016 PMID: 27679668 PMCID: PMC5029107 DOI: 10.1186/s13068-016-0614-y
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Concentrations (g/L) of each inhibitory compound in YPDI media
| Acids | Furans | Aromatics | |||
|---|---|---|---|---|---|
| Acetic acid | 2.000 | Furfural | 1.000 | 3,4-DHBA | 0.003 |
| Formic acid | 0.400 | Furoic acid | 0.020 | 3-HBA | 0.005 |
| Lactic acid | 0.100 | HMF | 2.000 | Benzoic acid | 0.015 |
| Succinic acid | 0.030 | Vanillic acid | 0.050 | ||
| Levulinic acid | 0.400 | Vanillin | 0.020 | ||
HMF hydroxymethylfurfural, DHBA dihydroxybenzaldehyde, HBA hydroxybenzaldehyde
Fig. 1Ethanol production in 17.5 % dw/v pretreated pine (3 % w/v SO2 at 210 °C for 10 min) by GHP1, GHP4, and XR122N. Solid lines represent cultures grown with the addition of inhibitors and dashed lines represent cultures grown in YPD only. Data show the average of three replicate fermentations
Concentrations of inhibitory compounds at the start and finish of pine fermentations
| Compound | Inoculaa | Initialb | Finalb | Changeb | Percent change (%) |
|---|---|---|---|---|---|
| Decreasing compounds | |||||
| Hydroxymethylfurfural | P | 1150.00 | 120.00 | −1030.00 | −89.6 |
| N | 1370.00 | 930.00 | −440.00 | −32.1 | |
| Furfural | P | 910.00 | 280.00 | −630.00 | −69.2 |
| N | 1130.00 | 900.00 | −230.00 | −20.4 | |
| Vanillin | P | 21.90 | 1.24 | −20.67 | −94.3 |
| N | 27.47 | 13.82 | −13.65 | −49.7 | |
| Lactic acid | P | 327.00 | 176.93 | −150.07 | −45.9 |
| N | 343.33 | 209.33 | −134.00 | −39.0 | |
| Benzoic acid | P | 44.03 | 34.83 | −9.20 | −20.9 |
| N | 42.80 | 31.33 | −11.47 | −26.8 | |
| 4-Hydroxybenzaldehyde | P | 3.72 | 0.27 | −3.46 | −92.7 |
| N | 4.21 | 2.08 | −2.13 | −50.6 | |
| Maleic acid | P | 8.13 | 6.48 | −1.66 | −20.3 |
| N | 8.27 | 1.43 | −6.84 | −82.7 | |
| 3,4-Dihydroxybenzaldehyde | P | 3.01 | 2.09 | −0.93 | −30.6 |
| N | 3.07 | 3.04 | −0.03 | −1.0 | |
| Itaconic acid | P | 1.77 | 1.59 | −0.18 | −10.2 |
| N | 1.67 | 1.38 | −0.29 | −17.4 | |
| Increasing compounds | |||||
| Succinic acid | P | 53.73 | 184.33 | +130.60 | 243.1 |
| N | 59.10 | 131.60 | +72.50 | 122.7 | |
| Vanillic acid | P | 30.93 | 57.10 | +26.17 | 84.6 |
| N | 27.35 | 42.10 | +14.75 | 53.9 | |
| Levulinic acid | P | 497.00 | 545.00 | +48.00 | 9.7 |
| N | 408.00 | 596.00 | +188.00 | 46.1 | |
| 2-Furoic acid | P | 24.20 | 45.05 | +20.85 | 86.2 |
| N | 21.70 | 43.83 | +22.13 | 102.0 | |
| 3-Hydroxy-4-methoxycinnamic acid | P | 8.48 | 14.03 | +5.56 | 65.4 |
| N | 4.10 | 7.38 | +3.28 | 80.0 | |
| 4-Hydroxybenzoic acid | P | 2.79 | 4.35 | +1.56 | 55.9 |
| N | 2.37 | 4.33 | +1.96 | 82.7 | |
| Glutaric acid | P | 2.75 | 4.10 | +1.35 | 49.1 |
| N | 2.52 | 3.67 | +1.15 | 45.6 | |
| 2,5-Dihydroxybenzoic acid | P | 0.14 | 0.48 | +0.35 | 242.9 |
| N | 0.07 | 0.18 | +0.11 | 157.1 | |
| Syringic acid | P | 3.55 | 3.86 | +0.31 | 8.7 |
| N | 3.09 | 3.13 | +0.04 | 1.3 | |
| 3,4-Dihydroxybenzoic acid | P | 3.51 | 3.55 | +0.04 | 1.1 |
| N | 2.11 | 3.01 | +0.89 | 42.7 | |
| Varying fluctuations | |||||
| | P | 2.46 | 5.14 | +2.68 | 108.9 |
| N | 2.51 | 0.91 | −1.60 | −63.7 | |
| | P | 2.49 | 3.04 | +0.55 | 22.1 |
| N | 1.40 | 1.03 | −0.37 | −26.4 | |
| | P | 59.53 | 46.97 | −12.57 | −21.1 |
| N | 50.15 | 57.45 | +7.30 | 14.6 | |
| Fumaric acid | P | 3.48 | 1.65 | −1.84 | −52.6 |
| N | 2.43 | 2.68 | +0.25 | 10.3 | |
| Homovanillic acid | P | 4.32 | 4.01 | −0.32 | −7.2 |
| N | 4.04 | 5.31 | +1.27 | 31.4 | |
| Malonic acid | P | 2.38 | 0.86 | −1.52 | −63.9 |
| N | 2.29 | 3.70 | +1.41 | 61.6 | |
aP represents average of performing inocula, N nonperforming b mg/L
Fig. 2Growth of strains in model fermentation media. Concentrations of inhibitors in the media were 1.13X of those listed in Table 1. Data represent the average of 20 replicate culture wells with error bars showing one standard deviation from the mean
Selected genes overexpressed in performing inocula
| Gene | Description | FCa |
|---|---|---|
| Fatty acid metabolism | ||
| | Peroxisomal acyl-CoA thioesterase, involved in fatty acid oxidation | 5.0 |
| | Peroxisomal ATP-binding cassette transporter | 2.7 |
| | Fatty acid desaturase, required for proper mitochondrial functioning | 2.6 |
| | Thioester reductase, required for proper mitochondrial functioning | 2.2 |
| General cellular metabolism | ||
| | Glyceraldehyde-3-phosphate dehydrogenase | 8.2 |
| | Dihydrofolate reductase, involved in tetrahydrofolate synthesis | 4.3 |
| | Aldehyde dehydrogenase | 4.2 |
| | Pyruvate decarboxylase | 4.0 |
| | Formate dehydrogenase | 3.8 |
| | Transketolase | 3.6 |
| | Asparagine synthetase | 3.1 |
| | Transcriptional activator for aromatic amino acid catabolism. | 2.9 |
| | Alcohol dehydrogenase | 2.9 |
| Membrane/cell wall associated | ||
| | Plasma membrane protein | 5.2 |
| | Implied regulator of ergosterol synthesis | 4.3 |
| | Glycosylated cell wall protein, required for Apn1p mitochondrial translocation | 2.3 |
| Transport | ||
| | Protein in the COPI coatomer | 4.6 |
| | Sorting nexin required for cytoplasm to vacuole targeting | 4.4 |
| | Exomer complex component | 4.4 |
| | Copper transporting P-type ATPase | 3.5 |
| | Putative FAD transporter | 3.4 |
| | Cadmium transporting P-type ATPase | 2.9 |
| | High affinity sulfate permease | 2.9 |
| | R-SNARE protein | 2.6 |
| | GTPase-activating protein | 2.6 |
| | ATP-binding cassette (ABC) transporter, multidrug transporter | 2.6 |
| | Plasma membrane multidrug transporter | 1.9 |
| Mitochondria associated | ||
| | Mitochondrial | 4.6 |
| | Unknown function, part of the mitochondrial proteome | 4.1 |
| | Mitochondrial RNA polymerase | 3.7 |
| | Unknown function, part of the mitochondrial proteome | 3.7 |
| | MutS Homologue involved in mitochondrial DNA repair | 3.4 |
| | Mitochondrial protein involved in translation of OLI1 mRNA | 3.4 |
| | Unknown function, part of the mitochondrial proteome | 2.8 |
| | Unknown function, part of the mitochondrial proteome | 2.8 |
| | Pleiotropic transcriptional regulator, involved in retrograde signaling | 2.7 |
| | Chaperone protein involved in SUMO-mediated protein degradation | 2.7 |
| | Mitochondrial DNA polymerase | 2.6 |
| | Unknown function, part of the mitochondrial proteome | 2.5 |
| | Proline oxidase | 2.5 |
| | Unknown function, part of the mitochondrial proteome | 2.5 |
| | Cytochrome b2 | 2.3 |
| | NADHX epimerase | 2.0 |
| |
| 2.0 |
| DNA stress response | ||
| | RNA Pol II transport factor, relocates to cytoplasm upon DNA stress | 4.4 |
| | Enolase I, converts 2-phosphoglycerate to phosphoenolpyruvate | 2.7 |
| | Inhibits carboxypeptidase Y and Ira2p | 2.4 |
| | Phosphatase involved in synthesis of trehalose | 2.0 |
| Oxidative stress response | ||
| | Cytosolic catalase T | 3.7 |
| | Glutathione transferase | 2.7 |
| | Glutamate decarboxylase | 2.1 |
| | Thiol-specific peroxiredoxin | 2.1 |
aFold change, average expression of performing inocula compared to nonperforming
Fig. 3Gene ontology analysis of DEGs identified from comparative transcriptomics. Functional classification of genes is based on a biological process, b molecular function, c protein class, and d cellular component. Percentage was calculated as the number of genes involved in the corresponding process out of total number of genes identified. Performed using PANTHER v.10 [35]
Fig. 4Validation of differential expression analysis by CT RT-PCR. Selected genes show relative differential expression using the nonperforming sample as reference
Fig. 5Fluorescence microscopy comparing mitochondria of performing and nonperforming samples using MitoTracker Green FM. a Wide field microscopy images of parent and evolved strains after 8 h growth in the presence and absence of inhibitory compounds. b Quantification of mitochondrial morphology. n = 100; experiments done in triplicate. Blue represents percentage of cells with intact tubular mitochondria. Red indicates percentage of cells with damaged/aggregated mitochondria